{"id":"https://openalex.org/W1493864240","doi":"https://doi.org/10.1002/9783527665211.ch15","title":"Development of Direct Thrombin Inhibitor, Dabigatran Etexilate, as an Anticoagulant Drug","display_name":"Development of Direct Thrombin Inhibitor, Dabigatran Etexilate, as an Anticoagulant Drug","publication_year":2014,"publication_date":"2014-06-13","ids":{"openalex":"https://openalex.org/W1493864240","doi":"https://doi.org/10.1002/9783527665211.ch15","mag":"1493864240"},"language":"en","primary_location":{"id":"doi:10.1002/9783527665211.ch15","doi":"https://doi.org/10.1002/9783527665211.ch15","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9783527665211.ch15","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Structure\u2010Based Design of Drugs and Other Bioactive Molecules","raw_type":"other"},"volume":{"id":"https://openalex.org/W3086353311","display_name":"Structure\u2010Based Design of Drugs and Other Bioactive Molecules"},"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041773055","display_name":"Arun Kumar Ghosh","orcid":"https://orcid.org/0000-0003-2472-1841","observed_orcids":["https://orcid.org/0000-0003-2472-1841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arun K. Ghosh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084867757","display_name":"Sandra Gemma","orcid":"https://orcid.org/0000-0002-8313-2417","observed_orcids":["https://orcid.org/0000-0002-8313-2417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Gemma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"337","last_page":"354"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran-etexilate","display_name":"dabigatran etexilate","score":0.9850000143051147},{"id":"https://openalex.org/keywords/direct-thrombin-inhibitors","display_name":"direct thrombin inhibitors","score":0.9100000262260437},{"id":"https://openalex.org/keywords/anticoagulant-drug-development","display_name":"anticoagulant drug development","score":0.8669999837875366},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8709999918937683},{"id":"https://openalex.org/keywords/x-ray-crystallography","display_name":"X-ray crystallography","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.9376528263092041},{"id":"https://openalex.org/C2776710957","wikidata":"https://www.wikidata.org/wiki/Q5280395","display_name":"Direct thrombin inhibitor","level":5,"score":0.7898211479187012},{"id":"https://openalex.org/C57002609","wikidata":"https://www.wikidata.org/wiki/Q5281999","display_name":"Discovery and development of direct thrombin inhibitors","level":4,"score":0.5600625276565552},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.542840301990509},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.5289937257766724},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.50596684217453},{"id":"https://openalex.org/C2910323407","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombins","level":4,"score":0.4331142008304596},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.42941814661026},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38542479276657104},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3625582754611969},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2085849642753601},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.20804864168167114},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.11945366859436035},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.04534652829170227}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/9783527665211.ch15","doi":"https://doi.org/10.1002/9783527665211.ch15","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9783527665211.ch15","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Structure\u2010Based Design of Drugs and Other Bioactive Molecules","raw_type":"other"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1811402656","https://openalex.org/W1963923094","https://openalex.org/W1972959684","https://openalex.org/W1983760732","https://openalex.org/W1992652027","https://openalex.org/W2011275596","https://openalex.org/W2021837301","https://openalex.org/W2022932023","https://openalex.org/W2032615313","https://openalex.org/W2046011250","https://openalex.org/W2056894234","https://openalex.org/W2066822578","https://openalex.org/W2067747440","https://openalex.org/W2067880085","https://openalex.org/W2093157914","https://openalex.org/W2094079380","https://openalex.org/W2095555302","https://openalex.org/W2095586887","https://openalex.org/W2109906659","https://openalex.org/W2121897924","https://openalex.org/W2133441668","https://openalex.org/W2133874799","https://openalex.org/W2141373630","https://openalex.org/W2143986922","https://openalex.org/W2165506983","https://openalex.org/W4232461495","https://openalex.org/W4250468389","https://openalex.org/W4251139957"],"related_works":["https://openalex.org/W1971941179","https://openalex.org/W2095803174","https://openalex.org/W2385158210","https://openalex.org/W1884320682","https://openalex.org/W2026375542","https://openalex.org/W2050646707","https://openalex.org/W1900240057","https://openalex.org/W2125175197","https://openalex.org/W2058927570","https://openalex.org/W2163591446"],"abstract_inverted_index":{"This":[0],"chapter":[1],"describes":[2],"a":[3],"detailed":[4],"account":[5],"of":[6,9,23],"the":[7,21],"development":[8],"direct":[10],"thrombin":[11],"inhibitor,":[12],"dabigatran":[13,40],"etexilate,":[14],"as":[15],"an":[16],"anticoagulant":[17],"drug.":[18],"It":[19],"covers":[20],"structure":[22],"thrombin,":[24],"structure\u2013activity":[25],"studies,":[26],"lead":[27],"amidine":[28],"compound,":[29],"X-ray":[30],"structural":[31],"studies":[32],"with":[33],"thrombin/hirudin":[34],"complex,":[35],"and":[36],"ultimate":[37],"optimization":[38],"to":[39],"ethyl":[41],"ester":[42],"prodrug.":[43]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}